Dear All,

Please note that this week we have a call scheduled for WT2. I know that a lot of individuals are traveling for a number of sessions and events being held throughout this week. Unfortunately, we are unable to reschedule the 1 February 2018 15 UTC call, so I invite individuals to comment and provide feedback over the mailing list. The topic for this week will be Closed Generics

As Sophia and I have highlighted in our emails over the last several weeks, we have been putting together documents that summarize, analyze, and offer paths forward for our topics in WT2. Already we have looked at the Registry Agreement, Registrant Protections, Reserved Names, and the Applicant Terms and Conditions. Documents have been circulated and shared with the group, but we have had very little feedback outside of our biweekly calls. I highly encourage participants to provide feedback on what we have highlighted and are proposing in these documents. The goal for these documents is to present to the overall WG what we are recommending as WT2.

I hope those of you that can join us will do so this week to engage in our discussion on Closed Generics.

Sincerely,

Michael Flemming & Sophia Feng
WT2 Co-Chairs